Baker Avenue Asset Management’s ResMed RMD Stock Holding History

Baker Avenue Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Buy	1,247 +404	+48%	+$101K	0.01%	626
2025 Q4	$203K	Sell	843 -175	-17%	-$44.8K	﹤0.01%	610
2025 Q3	$279K	Buy	+1,018	New	+$278K	0.01%	495
2023 Q4	–	Sell	-57	Closed	-$8.43K	–	1249
2023 Q3	$8.43K	Buy	57 +36	+171%	+$6.51K	﹤0.01%	803
2023 Q2	$4.59K	Sell	21 -2	-9%	-$446	﹤0.01%	868
2023 Q1	$5.04K	Buy	23 +2	+10%	+$434	﹤0.01%	869
2022 Q4	$4.37K	Buy	+21	New	+$4.61K	﹤0.01%	838

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baker Avenue Asset Management's RMD Position: Q1 2026 in Review

Baker Avenue Asset Management increased its ResMed (RMD) stake by 48% in Q1 2026, buying an estimated $101K and bringing the position to 1,247 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #626.

Baker Avenue Asset Management first reported a position in RMD in Q4 2022 and has held it in 7 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Baker Avenue Asset Management held 1,247 shares of ResMed worth $280K as of Q1 2026.
Baker Avenue Asset Management bought 404 ResMed shares in Q1 2026, an estimated $101K.
ResMed made up 0.01% of Baker Avenue Asset Management's portfolio in Q1 2026, its #626 holding.
Baker Avenue Asset Management first reported a position in ResMed in Q4 2022 and has held it in 7 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.